Cellular Dynamics International

Fujifilm, Axcelead Form Drug Discovery Services Alliance

The partners will offer drug discovery services based on human induced pluripotent stem cells and cells derived from these.

Cellular Dynamics International, Nanion Technologies Ink Comarketing Pact

The companies will offer CDI's human induced pluripotent stem cell-derived tissue cells with Nanion's ion channel drug discovery and screening platform.

Cellular Dynamics, Stemcell Technologies Ink iPSC Distribution Deal

Under the terms of the deal, Stemcell will distribute Cellular Dynamics' iCell line of induced pluripotent stem cell products.

Cellular Dynamics, Roche Ink $83M iPSC Supply and Licensing Deal

The Madison, Wisconsin-based firm, a subsidiary of Fujifilm, will supply iCell products to Roche for use in drug discovery.

Cellular Dynamics Signs Korea Distribution Deal with SeouLin Bioscience

SeouLin Bioscience will distribute the company's cell line products in the Republic of Korea, and provide first-level technical support for local customers.

May 4, 2015

Fujifilm Completes Acquisition of Cellular Dynamics

Mar 30, 2015

Fujifilm to Acquire Cellular Dynamics for $307M

Mar 6, 2015

Cellular Dynamics Q4 Revenues Up 57 Percent

Nov 11, 2014

Cellular Dynamics' Q3 Revenues Rise 41 Percent

Oct 27, 2014

NEI Awards Cellular Dynamics $1.2M Contract for iPSCs for Development of AMD Drug

Sep 3, 2014

Cellular Dynamics Files Shelf Registration for up to $90M

Aug 12, 2014

Cellular Dynamics' Q2 Revenues Rise 29 Percent

May 5, 2014

Cellular Dynamics Q1 Revenues Improve 21 Percent

Mar 10, 2014

Cellular Dynamics Q4 Revenues up 45 Percent

Jan 8, 2014

Cellular Dynamics Inks Supply Deal with Nestle

Dec 30, 2013

Coriell Awarded $7.7M Contract Extension by NINDS; Inks Agreement with CDI

Dec 9, 2013

Cellular Dynamics to Collaborate with Hamner on Toxicity Screening Assays

Dec 4, 2013

Cellular Dynamics, Jain Foundation Ink Stem Cell Line Deal

Nov 12, 2013

Cellular Dynamics Q3 Revenues up Sharply

Oct 4, 2013

In Brief This Week: Myriad Genetics, BioMarin; Quest; Genetic Analysis; Cedars-Sinai Medical Center, Exosome Diagnostics; More

Aug 29, 2013

Cellular Dynamics' Q2 Revenues More Than Double

Aug 19, 2013

UPDATE: Investment Banks Initiate Coverage of Cellular Dynamics with Outperform Ratings

Jul 31, 2013

Cellular Dynamics Nets $43M in IPO

Jul 25, 2013

Cellular Dynamics Prices IPO

Jul 10, 2013

Cellular Dynamics Prices IPO; Anticipates Raising up to $51M

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.